Active Clinical Trials of Interest in Endometrial Cancer Explore Novel Up-Front Approaches

Comparing the use of novel immunotherapeutic approaches with standard chemotherapy in the frontline setting represents a key focus of research in the endometrial cancer paradigm, according to Bradley R. Corr, MD.

minute read

Written by OncLive on January 27, 2022